Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Hickson, LaTonya J., Langhi Prata, Larissa G.P., Bobart, Shane A., Evans, Tamara K., Giorgadze, Nino, Hashmi, Shahrukh K., Herrmann, Sandra M., Jensen, Michael D., Jia, Qingyi, Jordan, Kyra L., KellogLanguage:
english
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2019.08.069
Date:
September, 2019
File:
PDF, 2.34 MB
english, 2019